Skip to main content
. 2023 Jun 16;15(6):1752. doi: 10.3390/pharmaceutics15061752

Figure 1.

Figure 1

Cytotoxicity of peptides against (a) RAW 264.7 cells, (b) L929, and (c) sheep red blood cells (sRBCs). Data are presented as the mean ± SEM from triplicate experiments. * p < 0.05, ** p < 0.01, *** p < 0.001; and ns, nonsignificant compared to that in the non-treatment group (two-way analysis of variance).